H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Census population 211,328. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Rochester clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Rochester storefront.
Collagen Injection Therapy in Rochester, NY for clinics & physicians. Collagen injection therapy products… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Obesity 38%; arthritis 24.9%. Those three PLACES crude rates (plus Census 211,328) are the local facts on this page. Everything else is the national collagen injection therapy catalog and JK paperwork.
National Collagen Injection Therapy notes (how the product actually works)Three grains, kept separate on purpose. City: Census 211,328 and CDC PLACES crude rates. State: New York State Department of Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and National Government Services (NGS) LCDs. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Adult arthritis here is 24.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Rochester.
CDC PLACES (2023, crude prevalence) estimates 14.3% of adults — 2.3 points above the U.S. 12% figure. Obesity is 38%; arthritis is 24.9%. That is place-level BRFSS modeling, not a clinic census and not a Rochester trial.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). New York State Department of Health is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Bring specialty, monthly joint / regenerative volume, and whether you bill JK FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 14.3% diabetes and 24.9% arthritis for Rochester — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Rochester, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Rochester is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Rochester — 2.3 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Rochester. Useful for joint-program math; still needs a diagnosis and privileging.
No Rochester storefront. Joe Bradley is an active practice owner. collagen injection therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.